Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
IL-11 (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
440
CHF
CHF 440.00
In stock
AG-40B-0266-C05050 µgCHF 440.00
NEW
Figure 1: Protein structure of IL-11 (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.) (Prod. No. AG-40B-0266).
| Product Details | |
|---|---|
| Synonyms | InVivoKine™; IL-11 (human) (monomeric):Fc (LALA-PG) Knobs-into-Holes (human) (rec.); Interleukin-11; Adipogenesis Inhibitory Factor; AGIF |
| Product Type | Protein |
| Properties | |
| Source/Host | HEK 293 cells. Produced using animal component-free medium. |
| Sequence |
Human IL-11 (aa 22-199) is fused at the C-terminus to the Fc portion of human IgG1 (LALA-PG) (Knobs-into-Holes technology) (see reference: J.B. Ridgway, et al.; Protein Eng. 9, 617 (1996)). |
| Crossreactivity |
Human Mouse |
| MW | ~ 50 kDa and 28kDa (SDS-PAGE) |
| Purity | ≥95% (SDS-PAGE) |
| Endotoxin Content | <0.002 EU/μg protein (LAL test). |
| Concentration | After reconstitution: 1mg/ml |
| Reconstitution | Reconstitute with 50μl endotoxin-free water. |
| Accession Number | P20809 |
| Formulation | Lyophilized. Contains PBS. |
| Protein Negative Control |
Fc (LALA-PG)-KIH (human) IgG1 Control (rec.) (Prod. No. AG-35B-0018) |
| Other Product Data |
Uniprot link P20809: IL-11 (human) |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
After reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. PBS containing at least 0.1% BSA should be used for further dilutions. |
| Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. |
| Documents | |
| MSDS | Inquire |
| Product Specification Sheet | |
| Datasheet |
 Download PDF |
Description
Interleukin-11 (IL-11) is a 19 kDa monomeric protein. IL-11 forms a hexameric signaling complex, which consists of the cytokine, the cognate receptor (IL-11Rα) and the common signaling receptor (GP130) in a 2:2:2 stoichiometry. Interleukin-11 (IL-11) belongs to the IL-6 family of cytokines, which includes IL-6, leukemia inhibitory factor, Oncostatin M, ciliary neurotrophic factor, cardiotrophin-1, cardiotrophin-like cytokine, neuropoietin, IL-27 and IL-31.
Interleukin-11 (IL-11) has diverse biological activities: i) it stimulates the proliferation and differentiation of hematopoietic stem cells and progenitor cells, enhances the production of megakaryocytes, leading to increased platelet production (thrombopoiesis); ii) IL-11 activates fibroblasts and exhibits either a pro-inflammatory or pro-fibrotic phenotype. Recently, IL-11 has been shown to be a key factor in 'inflammaging' (chronic inflammation), one of the hallmarks of aging leading to age-related illnesses, including cardiometabolic, neurodegenerative, musculoskeletal dysfunction and cancer. Inhibition of IL-11 has been shown to increase lifespan and health span in mice. IL-11 influences aging by inducing IL-33 in fibroblasts and NLRP3 in macrophages.
The protein IL-11 (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.) is produced by using two different vectors, one encoding for the IL-11 (human):Fc (LALA-PG) Knobs sequence (synthesizing a protein of 50 kDa) and one encoding for the Fc (LALA-PG) Holes sequence (synthesizing a protein of 28kDa). Both vectors transfected into HEK293 cells produce both Fc molecules (Knobs-into-Holes technology; J.B. Ridgway, et al.; Protein Eng. 9, 617 (1996)) required for dimerization of the Fc moieties and for secretion of the final protein IL-11 (human) (monomeric):Fc-KIH (human) (rec.). The LALA-PG mutations inhibit binding to FcγRs and C1q while FcRn binding and Fc stability remain unaffected.
InVivoKines™ are a new generation of recombinant fusion proteins for immunotherapeutic, preclinical and translational in vivo research, developed and manufactured by AdipoGen Life Sciences.
Related Products
